Jessica Lynn has an educational background in writing and marketing. She firmly believes in the power of writing in amplifying voices, and looks forward to doing so for the rare disease community.

    Enrollment Complete for Phase 3 Study Evaluating Brensocatib for Non-CF Bronchiectasis
    source: shutterstock.com

    Enrollment Complete for Phase 3 Study Evaluating Brensocatib for Non-CF Bronchiectasis

      People living with bronchiectasis, a chronic condition characterized by damaged airways, experience progressive lung damage and inflammation. This can lead to a multitude of consequences, including a reduction in…

    Continue Reading Enrollment Complete for Phase 3 Study Evaluating Brensocatib for Non-CF Bronchiectasis
    Rare Community Profiles: Their Daughter’s Rare Disease Empowered the Traller Family to Advocate for ASPS Awareness and Research
    source: shutterstock.com

    Rare Community Profiles: Their Daughter’s Rare Disease Empowered the Traller Family to Advocate for ASPS Awareness and Research

    Rare Community Profiles     Rare Community Profiles is a new Patient Worthy article series of long-form interviews featuring various stakeholders in the rare disease community, such as patients, their…

    Continue Reading Rare Community Profiles: Their Daughter’s Rare Disease Empowered the Traller Family to Advocate for ASPS Awareness and Research

    Pitolisant Reduced Excessive Daytime Sleepiness in Children with Narcolepsy

      Currently, the standards-of-care for narcolepsy include lifestyle changes involving diet and exercise, behavioral therapy, nap therapy, and certain medications designed to combat excessive daytime sleepiness. However, a majority of…

    Continue Reading Pitolisant Reduced Excessive Daytime Sleepiness in Children with Narcolepsy
    Rare Community Profiles: Reneo Pharmaceuticals is Developing Therapies for Rare Genetic Diseases like PMM and LC-FAOD
    source: shutterstock.com

    Rare Community Profiles: Reneo Pharmaceuticals is Developing Therapies for Rare Genetic Diseases like PMM and LC-FAOD

    Rare Community Profiles     Rare Community Profiles is a new Patient Worthy article series of long-form interviews featuring various stakeholders in the rare disease community, such as patients, their…

    Continue Reading Rare Community Profiles: Reneo Pharmaceuticals is Developing Therapies for Rare Genetic Diseases like PMM and LC-FAOD
    Do You Have a Child with Central Precocious Puberty (CPP)? Make Sure to Care for Yourself.
    Free-Photos / Pixabay

    Do You Have a Child with Central Precocious Puberty (CPP)? Make Sure to Care for Yourself.

      As many parents within the rare disease and chronic illness community know, it can sometimes be difficult to parent a medically complex child. It is important to practice self-care…

    Continue Reading Do You Have a Child with Central Precocious Puberty (CPP)? Make Sure to Care for Yourself.
    FDA Grants Accelerated Approval to Combination Treatment for Patients with Advanced or Metastatic Urothelial Carcinoma
    source: shutterstock.com

    FDA Grants Accelerated Approval to Combination Treatment for Patients with Advanced or Metastatic Urothelial Carcinoma

      According to reporting for Cure Today, the FDA recently granted Accelerated Approval to a combination treatment of Padcev (enfortumab vedotin-ejfv) and Keytruda (pembrolizumab) for advanced or metastatic urothelial carcinoma.…

    Continue Reading FDA Grants Accelerated Approval to Combination Treatment for Patients with Advanced or Metastatic Urothelial Carcinoma
    Family Raises Funds for PDCD Research After Daughter’s Diagnosis
    Source: https://pixabay.com/en/sky-clouds-rays-sun-hope-sunbeam-1107952/

    Family Raises Funds for PDCD Research After Daughter’s Diagnosis

    The Higbee family never planned to become rare disease advocates. But when their daughter Harlow began experiencing health issues, they knew that they would do whatever they could to help.…

    Continue Reading Family Raises Funds for PDCD Research After Daughter’s Diagnosis
    A Cystic Fibrosis Diagnosis No Longer Automatically Qualifies for Make-A-Wish
    https://pixabay.com/en/little-girl-praying-people-wishing-1894125/

    A Cystic Fibrosis Diagnosis No Longer Automatically Qualifies for Make-A-Wish

      Children with cystic fibrosis (CF) born between 1995 and 1999 had an estimated life expectancy of 32 years. Advances in both research and treatment have contributed to increased life…

    Continue Reading A Cystic Fibrosis Diagnosis No Longer Automatically Qualifies for Make-A-Wish
    Cyclosporine Contributes to Long-Term Treatment Efficacy in Ulcerative Colitis (UC)
    Photo by Paweł Czerwiński on Unsplash

    Cyclosporine Contributes to Long-Term Treatment Efficacy in Ulcerative Colitis (UC)

    Certain patients with ulcerative colitis (UC) do not respond well to steroid treatment. These patients are considered to have steroid-refractory acute severe ulcerative colitis, or ASUC. Other therapeutic options, such…

    Continue Reading Cyclosporine Contributes to Long-Term Treatment Efficacy in Ulcerative Colitis (UC)